Waivers and Alterations of Research Informed Consent During the COVID-19 Pandemic

Ann Intern Med. 2021 Mar;174(3):415-416. doi: 10.7326/M20-6993. Epub 2020 Dec 15.

Abstract

The COVID-19 pandemic poses distinct challenges for the conduct of minimal-risk clinical research, including the very definition of minimal risk, the heterogeneity of risk among potential study participants, privacy concerns, and practical issues in recruitment and written informed consent.

Publication types

  • Editorial

MeSH terms

  • Biomedical Research / ethics*
  • COVID-19 / epidemiology*
  • Ethics Committees, Research
  • Humans
  • Informed Consent / ethics*
  • Pandemics*
  • Risk Assessment
  • SARS-CoV-2
  • Vulnerable Populations